Trial Profile
A pilot phase II study of bertilimumab for the treatment of non-alcoholic-steatohepatitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2015
Price :
$35
*
At a glance
- Drugs Bertilimumab (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 18 Apr 2015 New trial record
- 15 Apr 2015 Immune Pharmaceuticals plans to initiate this study before the end of 2015.